Cargando…
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
Prostate Cancer (PCa) diagnosis is currently hampered by the high false-positive rate of PSA evaluations, which consequently may lead to overtreatment. Non-invasive methods with increased specificity and sensitivity are needed to improve diagnosis of significant PCa. We developed and technically val...
Autores principales: | Endt, Kathrin, Goepfert, Jens, Omlin, Aurelius, Athanasiou, Alcibiade, Tennstedt, Pierre, Guenther, Anna, Rainisio, Maurizio, Engeler, Daniel S., Steuber, Thomas, Gillessen, Silke, Joos, Thomas, Schiess, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540289/ https://www.ncbi.nlm.nih.gov/pubmed/28767721 http://dx.doi.org/10.1371/journal.pone.0181557 |
Ejemplares similares
-
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018) -
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology
por: Athanasiou, Alcibiade, et al.
Publicado: (2021) -
Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer
por: Klocker, Helmut, et al.
Publicado: (2020) -
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer
por: Macagno, Annalisa, et al.
Publicado: (2020) -
In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions
por: Pratsinis, Manolis, et al.
Publicado: (2021)